Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nicole Gastineau Campos, Ph.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Shastri SS, Temin S, Almonte M, Basu P, Campos NG, Gravitt PE, Gupta V, Lombe DC, Murillo R, Nakisige C, Ogilvie G, Pinder LF, Poli UR, Qiao Y, Woo YL, Jeronimo J. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline Update. JCO Glob Oncol. 2022 09; 8:e2200217. PMID: 36162041.
    Citations:    Fields:    Translation:HumansPHPublic Health
  2. Adebamowo SN, Befano B, Cheung LC, Rodriguez AC, Demarco M, Rydzak G, Chen X, Porras C, Herrero R, Kim JJ, Castle PE, Wentzensen N, Kreimer AR, Schiffman M, Campos NG. Different human papillomavirus types share early natural history transitions in immunocompetent women. Int J Cancer. 2022 09 15; 151(6):920-929. PMID: 35603904; PMCID: PMC9329241.
    Citations:    Fields:    Translation:HumansCells
  3. Barnard-Mayers R, Kouser H, Cohen JA, Tassiopoulos K, Caniglia EC, Moscicki AB, Campos NG, Caunca MR, Seage GRS, Murray EJ. A case study and proposal for publishing directed acyclic graphs: The effectiveness of the quadrivalent human papillomavirus vaccine in perinatally HIV Infected girls. J Clin Epidemiol. 2022 04; 144:127-135. PMID: 34998951; PMCID: PMC8977269.
    Citations:    Fields:    Translation:Humans
  4. Desai KT, Befano B, Xue Z, Kelly H, Campos NG, Egemen D, Gage JC, Rodriguez AC, Sahasrabuddhe V, Levitz D, Pearlman P, Jeronimo J, Antani S, Schiffman M, de Sanjosé S. The development of "automated visual evaluation" for cervical cancer screening: The promise and challenges in adapting deep-learning for clinical testing: Interdisciplinary principles of automated visual evaluation in cervical screening. Int J Cancer. 2022 03 01; 150(5):741-752. PMID: 34800038; PMCID: PMC8732320.
    Citations: 1     Fields:    Translation:HumansCells
  5. Porras C, Sampson JN, Herrero R, Gail MH, Cortés B, Hildesheim A, Cyr J, Romero B, Schiller JT, Montero C, Pinto LA, Schussler J, Coronado K, Sierra MS, Kim JJ, Torres CM, Carvajal L, Wagner S, Campos NG, Ocampo R, Kemp TJ, Zuniga M, Lowy DR, Avila C, Chanock S, Castrillo A, Estrada Y, Barrientos G, Monge C, Oconitrillo MY, Kreimer AR. Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial. Vaccine. 2022 01 03; 40(1):76-88. PMID: 34857420; PMCID: PMC8759448.
    Citations: 1     Fields:    Translation:HumansCells
  6. Spencer JC, Campos NG, Burger EA, Sy S, Kim JJ. Potential effectiveness of a therapeutic HPV intervention campaign in Uganda. Int J Cancer. 2022 03 01; 150(5):847-855. PMID: 34741526; PMCID: PMC8732308.
    Citations:    Fields:    Translation:HumansPHPublic Health
  7. Campos NG, Chaturvedi AK, Kreimer AR. Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies. J Natl Cancer Inst. 2021 10 01; 113(10):1270-1271. PMID: 33876237.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  8. Portnoy A, Campos NG, Sy S, Burger EA, Cohen J, Regan C, Kim JJ. Retraction: Impact and Cost-effectiveness of Human Papillomavirus Vaccination Campaigns. Cancer Epidemiol Biomarkers Prev. 2021 Jun; 30(6):1283. PMID: 34074734.
    Citations:    Fields:    
  9. Paul P, Hammer A, Rositch AF, Burke AE, Viscidi RP, Silver MI, Campos N, Youk AO, Gravitt PE. Rates of New Human Papillomavirus Detection and Loss of Detection in Middle-aged Women by Recent and Past Sexual Behavior. J Infect Dis. 2021 04 23; 223(8):1423-1432. PMID: 32870982; PMCID: PMC8064050.
    Citations: 7     Fields:    Translation:HumansCells
  10. Campos NG, Scarinci IC, Tucker L, Peral S, Li Y, Regan MC, Sy S, Castle PE, Kim JJ. Cost-Effectiveness of Offering Cervical Cancer Screening with HPV Self-Sampling among African-American Women in the Mississippi Delta. Cancer Epidemiol Biomarkers Prev. 2021 06; 30(6):1114-1121. PMID: 33771846.
    Citations: 1     Fields:    Translation:HumansCells
  11. Campos NG, Demarco M, Bruni L, Desai KT, Gage JC, Adebamowo SN, de Sanjose S, Kim JJ, Schiffman M. A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer. Prev Med. 2021 03; 144:106438. PMID: 33678235; PMCID: PMC8041229.
    Citations: 6     Fields:    Translation:HumansCells
  12. Scarinci IC, Li Y, Tucker L, Campos NG, Kim JJ, Peral S, Castle PE. Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial. Prev Med. 2021 01; 142:106358. PMID: 33338505.
    Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
  13. Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ. Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries. Int J Cancer. 2021 02 15; 148(4):932-940. PMID: 32706907.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
  14. Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X, Hammer A, Campos N, Kinney W, Gage JC, Befano B, Perkins RB, He X, Dallal C, Chen J, Poitras N, Mayrand MH, Coutlee F, Burk RD, Lorey T, Castle PE, Wentzensen N, Schiffman M. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. EClinicalMedicine. 2020 May; 22:100293. PMID: 32510043; PMCID: PMC7264956.
    Citations: 21     
  15. Hammer A, Demarco M, Campos N, Befano B, Gravitt PE, Cheung L, Lorey TS, Poitras N, Kinney W, Wentzensen N, Castle PE, Schiffman M. A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California. Int J Cancer. 2020 09 15; 147(6):1612-1620. PMID: 32141607.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  16. Campos NG, Alfaro K, Maza M, Sy S, Melendez M, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M, Kim JJ. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador. Prev Med. 2020 02; 131:105931. PMID: 31765712.
    Citations: 2     Fields:    Translation:HumansCells
  17. Portnoy A, Campos NG, Sy S, Burger EA, Cohen J, Regan C, Kim JJ. Impact and Cost-Effectiveness of Human Papillomavirus Vaccination Campaigns. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):22-30. PMID: 31666282.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  18. Canfell K, Kim JJ, Kulasingam S, Berkhof J, Barnabas R, Bogaards JA, Campos N, Jennett C, Sharma M, Simms KT, Smith MA, Velentzis LS, Brisson M, Jit M. HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control. Papillomavirus Res. 2019 12; 8:100184. PMID: 31505258; PMCID: PMC6804684.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  19. Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Masch R, Cremer M, Kim JJ. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador. Int J Gynaecol Obstet. 2019 Apr; 145(1):40-46. PMID: 30702142; PMCID: PMC6988124.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  20. Campos NG, Tsu V, Jeronimo J, Regan C, Resch S, Clark A, Sy S, Kim JJ. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis. Int J Cancer. 2019 02 15; 144(4):687-696. PMID: 30132850; PMCID: PMC6519250.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  21. Campos NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, Smith JS, Michelow P, Meyer-Rath G, Jamieson L, Jordaan S, Sharma M, Regan C, Sy S, Liu G, Tsu V, Jeronimo J, Kim JJ. Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study. J Acquir Immune Defic Syndr. 2018 10 01; 79(2):195-205. PMID: 29916959; PMCID: PMC6143200.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  22. Mezei AK, Pedersen HN, Sy S, Regan C, Mitchell-Foster SM, Byamugisha J, Sekikubo M, Armstrong H, Rawat A, Singer J, Ogilvie GS, Kim JJ, Campos NG. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial. BMJ Open. 2018 06 12; 8(6):e020484. PMID: 29895648.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  23. Burger EA, Campos NG, Sy S, Regan C, Kim JJ. Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country. Vaccine. 2018 08 06; 36(32 Pt A):4823-4829. PMID: 29807710.
    Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
  24. Castle PE, Wheeler CM, Campos NG, Sy S, Burger EA, Kim JJ. Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S. Prev Med. 2018 06; 111:177-179. PMID: 29548787.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  25. Campos NG, Tsu V, Jeronimo J, Njama-Meya D, Mvundura M, Kim JJ. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting. Health Policy Plan. 2017 Dec 01; 32(10):1491. PMID: 28973511.
    Citations:    Fields:    
  26. Campos NG, Tsu V, Jeronimo J, Mvundura M, Kim JJ. Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study. BMC Cancer. 2017 Nov 25; 17(1):791. PMID: 29178896.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  27. Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):158-164. PMID: 29150480; PMCID: PMC5809257.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  28. Campos NG, Tsu V, Jeronimo J, Njama-Meya D, Mvundura M, Kim JJ. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting. Health Policy Plan. 2017 09 01; 32(7):956-968. PMID: 28369405; PMCID: PMC5886074.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  29. Campos NG, Jeronimo J, Tsu V, Castle PE, Mvundura M, Kim JJ. The Cost-Effectiveness of Visual Triage of Human Papillomavirus-Positive Women in Three Low- and Middle-Income Countries. Cancer Epidemiol Biomarkers Prev. 2017 10; 26(10):1500-1510. PMID: 28710075.
    Citations: 6     Fields:    Translation:Humans
  30. Campos NG, Tsu V, Jeronimo J, Mvundura M, Kim JJ. Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings. Cancer Med. 2017 Aug; 6(8):2008-2014. PMID: 28707435.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  31. Campos NG, Sharma M, Clark A, Lee K, Geng F, Regan C, Kim J, Resch S. The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries. Int J Gynaecol Obstet. 2017 Jul; 138 Suppl 1:47-56. PMID: 28691334.
    Citations: 18     Fields:    Translation:HumansPHPublic Health
  32. Campos NG, Mvundura M, Jeronimo J, Holme F, Vodicka E, Kim JJ. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua. BMJ Open. 2017 06 15; 7(6):e015048. PMID: 28619772.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  33. Mezei AK, Armstrong HL, Pedersen HN, Campos NG, Mitchell SM, Sekikubo M, Byamugisha JK, Kim JJ, Bryan S, Ogilvie GS. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review. Int J Cancer. 2017 08 01; 141(3):437-446. PMID: 28297074.
    Citations: 41     Fields:    Translation:Humans
  34. Campos NG, Tsu V, Jeronimo J, Mvundura M, Lee K, Kim JJ. To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings. Int J Cancer. 2017 03 15; 140(6):1293-1305. PMID: 27925175; PMCID: PMC5516173.
    Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
  35. Maza M, Alfaro K, Garai J, Velado MM, Gage JC, Castle PE, Felix J, Luciani S, Campos N, Kim J, Masch R, Cremer M. Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country. Gynecol Oncol Rep. 2017 May; 20:58-61. PMID: 28337474; PMCID: PMC5352717.
    Citations: 10     
  36. Kim JJ, Burger EA, Sy S, Campos NG. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus. J Natl Cancer Inst. 2017 Feb 01; 109(2):1-9. PMID: 28376222.
  37. Kim JJ, Burger EA, Sy S, Campos NG. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus. J Natl Cancer Inst. 2017 02; 109(2). PMID: 27754955; PMCID: PMC5068562.
    Citations: 27     Fields:    Translation:HumansCellsPHPublic Health
  38. Campos NG, Sharma M, Clark A, Kim JJ, Resch SC. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries. PLoS One. 2016; 11(10):e0164000. PMID: 27711124.
    Citations: 15     Fields:    Translation:HumansPHPublic Health
  39. Kim JJ, Campos NG, Sy S, Burger EA, Cuzick J, Castle PE, Hunt WC, Waxman A, Wheeler CM. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis. Ann Intern Med. 2015 Oct 20; 163(8):589-97. PMID: 26414147; PMCID: PMC5104349.
    Citations: 32     Fields:    Translation:HumansPHPublic Health
  40. Campos NG, Castle PE, Wright TC, Kim JJ. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage. Int J Cancer. 2015 Nov 01; 137(9):2208-19. PMID: 25943074; PMCID: PMC4910518.
    Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
  41. Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Cremer ML, Kim JJ. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador. Int J Cancer. 2015 Aug 15; 137(4):893-902. PMID: 25639903.
    Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
  42. Seay JS, Carrasquillo O, Campos NG, McCann S, Amofah A, Pierre L, Kobetz E. Cancer Screening Utilization Among Immigrant Women in Miami, Florida. Prog Community Health Partnersh. 2015; 9 Suppl:9. PMID: 26213399.
  43. Seay JS, Carrasquillo O, Campos NG, McCann S, Amofah A, Pierre L, Kobetz E. Cancer Screening Utilization Among Immigrant Women in Miami, Florida. Prog Community Health Partnersh. 2015; 9 Suppl:11-20. PMID: 26213400.
    Citations: 14     Fields:    Translation:Humans
  44. Campos NG, Burger EA, Sy S, Sharma M, Schiffman M, Rodriguez AC, Hildesheim A, Herrero R, Kim JJ. An updated natural history model of cervical cancer: derivation of model parameters. Am J Epidemiol. 2014 Sep 01; 180(5):545-55. PMID: 25081182.
    Citations: 48     Fields:    Translation:HumansCells
  45. Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa. Vaccine. 2013 Dec 29; 31 Suppl 5:F60-72. PMID: 24331749.
    Citations: 18     Fields:    Translation:Humans
  46. Kiatpongsan S, Campos NG, Kim JJ. Potential benefits of second-generation human papillomavirus vaccines. PLoS One. 2012; 7(11):e48426. PMID: 23144879.
    Citations: 7     Fields:    Translation:HumansCells
  47. Kobetz E, Kish JK, Campos NG, Koru-Sengul T, Bishop I, Lipshultz H, Barton B, Barbee L. Burden of Human Papillomavirus among Haitian Immigrants in Miami, Florida: Community-Based Participatory Research in Action. J Oncol. 2012; 2012:728397. PMID: 22619675.
    Citations: 11     
  48. Campos NG, Castle PE, Schiffman M, Kim JJ. Policy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage Study. Med Decis Making. 2012 May-Jun; 32(3):400-27. PMID: 22147881.
    Citations: 1     Fields:    Translation:Humans
  49. Campos NG, Kim JJ, Castle PE, Ortendahl JD, O'Shea M, Diaz M, Goldie SJ. Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa. Int J Cancer. 2012 Jun 01; 130(11):2672-84. PMID: 21717458.
    Citations: 42     Fields:    Translation:HumansCellsPHPublic Health
  50. Campos NG, Rodriguez AC, Castle PE, Herrero R, Hildesheim A, Katki H, Kim JJ, Wacholder S, Morales J, Burk RD, Schiffman M. Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study. J Infect Dis. 2011 Mar 15; 203(6):823-7. PMID: 21257737; PMCID: PMC3071138.
    Citations: 14     Fields:    Translation:HumansCells
  51. Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine. 2008 Jul 29; 26(32):4080-93. PMID: 18550229.
    Citations: 69     Fields:    Translation:HumansCellsPHPublic Health
  52. Campos NG, Salomon JA, Servoss JC, Nunes DP, Samet JH, Freedberg KA, Goldie SJ. Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV. Am J Med. 2007 Mar; 120(3):272-9. PMID: 17349451; PMCID: PMC2034752.
    Citations: 5     Fields:    Translation:Humans
  53. Farmer P, Campos NG. Rethinking medical ethics: a view from below. Dev World Bioeth. 2004 May; 4(1):17-41. PMID: 15086372.
    Citations: 9     Fields:    Translation:Humans
  54. Farmer P, Campos NG. New malaise: bioethics and human rights in the global era. J Law Med Ethics. 2004; 32(2):243-51, 190-1. PMID: 15301189.
    Citations: 8     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Campos's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (151)
Co-Authors (9)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.